Moreover, the overall survival times and disease-free survival appeared to be shorter in lung cancer patients with higher PROX1 and were prolonged in cases of higher Ser79 phosphorylation (Fig. 7g–j). The gene discussed is PROX1; the disease is lung carcinoma.